SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-021594
Filing Date
2024-03-12
Accepted
2024-03-12 08:37:39
Documents
5
Effectiveness Date
2024-03-12

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0201545-s8_cadrenal.htm S-8 36236
2 OPINION OF BLANK ROME LLP ea020154501ex5-1_cadrenal.htm EX-5.1 9500
3 CONSENT OF WITHUMSMITH + BROWN, PC, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIR ea020154501ex23-1_cadrenal.htm EX-23.1 1953
4 FILING FEE TABLE ea020154501ex-fee_cadrenal.htm EX-FILING FEES 14127
5 GRAPHIC ex5-1_001.jpg GRAPHIC 2405
  Complete submission text file 0001213900-24-021594.txt   66325
Mailing Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082
Business Address 822 A1A NORTH SUITE 300 PONTE VEDRA FL 32082 904-300-0701
Cadrenal Therapeutics, Inc. (Filer) CIK: 0001937993 (see all company filings)

IRS No.: 880860746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277838 | Film No.: 24740321
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)